Literature DB >> 136582

Huntington's disease: regional alteration in muscarinic cholinergic receptor binding in human brain.

G J Wastek, L Z Stern, P C Johnson, H I Yamamura.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 136582     DOI： 10.1016/0024-3205(76)90295-2

Source DB:  PubMed          Journal:  Life Sci        ISSN： 0024-3205            Impact factor:   5.037


× No keyword cloud information.
  4 in total

1.  The subcellular fractionation of the bovine caudate nucleus.

Authors:  M R Gregg; S Spanner; G B Ansell
Journal:  Neurochem Res       Date:  1982-09       Impact factor: 3.996

2.  Human serum Cohn fraction IV (alpha-globulin [correction of globin] enriched) inhibits ligand binding at neurotransmitter receptors in human brain.

Authors:  A C Andorn; M A Pappolla; H Fox; F K Klemens; P A Martello
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

Review 3.  Targeting the Cholinergic System to Develop a Novel Therapy for Huntington's Disease.

Authors:  Gary X D'Souza; Henry J Waldvogel
Journal:  J Huntingtons Dis       Date:  2016-12-15

Review 4.  Recurrent Implication of Striatal Cholinergic Interneurons in a Range of Neurodevelopmental, Neurodegenerative, and Neuropsychiatric Disorders.

Authors:  Lauren A Poppi; Khue Tu Ho-Nguyen; Anna Shi; Cynthia T Daut; Max A Tischfield
Journal:  Cells       Date:  2021-04-15       Impact factor: 6.600
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.